- Home
- VYNE vs ASRV Comparison
VYNE vs ASRV Comparison
Compare VYNE & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- ASRV
- Stock Information
- Founded
- VYNE 2003
- ASRV 1983
- Country
- VYNE United States
- ASRV United States
- Employees
- VYNE N/A
- ASRV N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- ASRV Major Banks
- Sector
- VYNE Health Care
- ASRV Finance
- Exchange
- VYNE Nasdaq
- ASRV Nasdaq
- Market Cap
- VYNE 35.7M
- ASRV 40.3M
- IPO Year
- VYNE 2018
- ASRV N/A
- Fundamental
- Price
- VYNE $1.85
- ASRV $2.35
- Analyst Decision
- VYNE Strong Buy
- ASRV
- Analyst Count
- VYNE 2
- ASRV 0
- Target Price
- VYNE $6.88
- ASRV N/A
- AVG Volume (30 Days)
- VYNE 224.4K
- ASRV 29.4K
- Earning Date
- VYNE 05-08-2025
- ASRV 04-29-2025
- Dividend Yield
- VYNE N/A
- ASRV 5.13%
- EPS Growth
- VYNE N/A
- ASRV N/A
- EPS
- VYNE N/A
- ASRV 0.21
- Revenue
- VYNE $501,000.00
- ASRV $53,139,000.00
- Revenue This Year
- VYNE N/A
- ASRV N/A
- Revenue Next Year
- VYNE N/A
- ASRV N/A
- P/E Ratio
- VYNE N/A
- ASRV $11.19
- Revenue Growth
- VYNE 18.16
- ASRV 18.14
- 52 Week Low
- VYNE $1.44
- ASRV $2.03
- 52 Week High
- VYNE $4.30
- ASRV $3.06
- Technical
- Relative Strength Index (RSI)
- VYNE 53.21
- ASRV 51.76
- Support Level
- VYNE $1.76
- ASRV $2.07
- Resistance Level
- VYNE $1.93
- ASRV $2.52
- Average True Range (ATR)
- VYNE 0.16
- ASRV 0.13
- MACD
- VYNE 0.06
- ASRV 0.00
- Stochastic Oscillator
- VYNE 83.67
- ASRV 68.09
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.